Page 310 - PROGRAMME2018

P-659 Occurrence and characteristics of recombinant human follicle-stimulating hormone (r-hFSH) dose adjustments during ovarian stimulation in a real-world US database study of 33,962 IVF patient cycles
M. Mahony1, B. Hayward2, K. Richter3, T. D'Hooghe4
1EMD Serono- Inc., Medical Affairs - Endocrinology/Reproductive Health, Rockland- MA, U.S.A. 2EMD Serono- Inc., Global Biostatistics & Epidemiology, Rockland- MA, U.S.A.
3Shady Grove Fertility Reproductive Science Center, Research, Rockville, U.S.A.
4Merck KGaA, Global Medical Affairs Fertility, Darmstadt, Germany
P-660 Long-term health related quality of life (HRQoL), life satisfaction and health status in women with PCOS -a population-based follow-up analysis at ages 31 and 46
S. Karjula1, L. Morin-Papunen1, J. Auvinen2, S. Franks3, M.R. Järvelin4, J. Tapanainen5, J. Jokelainen6, J. Miettunen2, T. Piltonen1
1Oulu University Hospital- University of Oulu- Medical Research Center Oulu and PEDEGO Research Unit, Obstetrics and Gynecology, Oulu, Finland
2University of Oulu- Medical Research Center Oulu and Oulu University Hospital, Center for Life Course Health Research, Oulu, Finland
3Imperial College, Institute of Reproductive and Developmental Biology, London, United Kingdom
4Imperial College, Department of Epidemiology and Biostatistics- Medical Research Council- PHE Public Health England Centre for Environment & Health- School of Public Health, London, United Kingdom
5Oulu University Hospital- University of Oulu- Medical Research Center Oulu- PEDEGO Research Unit Oulu- University of Helsinki and Helsinki University Hospital, Obstetrics and Gynecology,
Oulu- Helsinki, Finland
6University of Oulu, Faculty of Medicine, Oulu, Finland
P-662 Co-administration of GnRH-agonist and a standard dose of hCG (dual trigger) for improving IVF outcome in patients with low proportion of mature oocyte
L. Wang1, Y. Wang1
1Peking University Third Hospital, Department of Obstetrics and Gynecology, Beijing, China
P-663 Relevance of prednisolone treatment in patients with multipronuclear embryos caused by anticentromere antibodies: improvement of fertilization, blastocyst formation and pregnancy rates
M. Inoue1, S. Mizuta1,2, H. Matsubayashi1,2, T. Takeuchi2, K. Kitaya1, T. Ishikawa1,2 1Reproduction Clinic Osaka, reproductive medicine, Osaka, Japan 2Reproduction Clinic Tokyo, reproductive medicine, Tokyo, Japan
310